IP Library Granted Patent US 10,940,233
Granted Patent B2
US 10,940,233 · App. 16/338,803 · Granted Mar 9, 2021

Fibrinogen composition, method and wound articles

Inventors: James P. Dizio (Saint Paul, MN); Zhicheng Tian (Woodbury, MN); Jason W. Bjork (Cottage Grove, MN); Amy S. Determan (Mahtomedi, MN); Robert A. Asmus (Hudson, WI); Jonathan J. O'Hare (Oakdale, MN)
Assignee: 3M Innovative Properties Company
A61L26/0042A61L26/008A61L2300/418
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,940,233
App. No.
16/338,803
Granted
Mar 9, 2021
Kind
B2
Abstract

Provided is a method of forming a fibrinogen hydrogel composition, the method including providing a fibrinogen hydrogel or precursor thereof, comprising fibrinogen hydrogel forming salt. The fibrinogen hydrogel forming salt concentration is greater than or equal to the threshold concentration to form a fibrinogen hydrogel. The method further includes denaturing the fibrinogen hydrogel such as by heating. The method optionally further includes combining the fibrinogen hydrogel with a carrier material. When present, the concentration of the carrier material typically ranges from 0.1 to about 50 wt.-%. The method further includes reducing the salt concentration below the threshold concentration to form a fibrinogen hydrogel.

Claims (23)

1. A method of forming a fibrinogen hydrogel composition comprising:

providing a fibrinogen hydrogel or precursor thereof, comprising fibrinogen hydrogel forming salt at a concentration greater than or equal to the threshold concentration to form the fibrinogen hydrogel;

denaturing the fibrinogen hydrogel;

reducing the salt concentration below the threshold concentration to form the fibrinogen hydrogel.

2. The method of claim 1 , wherein the fibrinogen hydrogel precursor comprises an aqueous solution comprising fibrinogen and the fibrinogen hydrogel forming salt.

3. The method of claim 1 , wherein the fibrinogen hydrogel forming salt comprises sodium citrate optionally in combination with sodium chloride.

4. The method of claim 1 , wherein the threshold hydrogel forming salt concentration of the aqueous solution is at least 0.45 wt.-%.

5. The method of claim 1 , wherein the fibrinogen hydrogel composition further comprises a fibrinogen hydrogel plasticizer.

6. The method of claim 5 wherein the plasticizer comprises a sugar alcohol, an alkane diol, or a combination thereof.

7. The method of claim 1 , further comprising forming the fibrinogen hydrogel composition into a sheet, foam, or a plurality of pieces.

8. The method of claim 1 , wherein the step of reducing the fibrinogen hydrogel forming salt concentration comprises rinsing the hydrogel with an aqueous solution.

9. The method of claim 1 , further comprising dehydrating the fibrinogen hydrogel composition.

10. The method of claim 1 , wherein the denaturing is accomplished by heating.

11. The method of claim 9 , wherein the dehydrated denatured fibrinogen hydrogel composition has a salt concentration no greater than 20 wt.-%.

12. The method of claim 1 , further comprising forming the fibrinogen hydrogel composition into a plurality of pieces.

13. The method of claim 1 , further comprising combining the fibrinogen hydrogel with 0.1 to about 50 wt.-% of a carrier material.

14. The method of claim 13 , wherein the carrier material comprises a water soluble polymer having a Fikentscher K-value of at least K-90.

15. The method of claim 13 , wherein the carrier material comprises a polymer.

16. The method of claim 15 , wherein the polymer comprises polymerized units of N-vinyl lactam polymer.

17. The method of claim 13 , wherein the carrier material further comprises a swelling agent.

18. The method of claim 17 , wherein the swelling agent also functions as a plasticizer for the fibrinogen hydrogel.

19. The method of claim 1 , wherein reducing the salt concentration below the threshold concentration to form the fibrinogen hydrogel is before combining the fibrinogen hydrogel with a carrier material.

20. The method of claim 1 , wherein reducing the salt concentration below the threshold concentration to form the fibrinogen hydrogel is after combining the fibrinogen hydrogel with a carrier material.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0295 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2019
From: DIZIO, JAMES P.; TIAN, ZHICHENG; BJORK, JASON W.; DETERMAN, AMY S.; ASMUS, ROBERT A.; O'HARE, JONATHAN J.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 048766/0960 →